Telehealth soared in popularity last year, and it wasn’t all due to the COVID-19 pandemic. Health officials were already seeing a surge in traffic before the public health crisis began. According to data from the Centers for Disease Control and Prevention (CDC), in the first three months of 2020, the number of telehealth visits were up 50% from the same period last year, and the majority of them weren’t to treat or address concerns related to COVID-19.
One stock that’s benefited from the growth in telehealth over the past year is Teladoc Health (NYSE: TDOC). It’s arguably become the early leader in telehealth, and with its recent acquisition of Livongo now complete, it’s an even bigger and better diversified healthcare stock.
How much money could you have made from investing in Teladoc shares a year ago, before the massive growth in telehealth? Let’s take a closer look and see how well the stock has performed, and whether it’s still a good buy.